Articles Archive - Page 702 of 821

Letter: RA Approval for IL-1Ra

William Arend, MD | February 3, 2012

Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.

Arthritis in Winter

Sue Pondrom | January 18, 2012

Fewer daylight hours impact both RA and OA

Prevalence of Gout and Hyperuricemia Increase in U.S.

Sue Pondrom | January 18, 2012

Causes include sedentary lifestyle, an increased frequency of obesity and hypertension, diuretic use, and alcohol intake

Antiphospholipid Antibody Testing Update

Staff | January 13, 2012

Successes, challenges, and controversies of diagnostic methods for APS

New Year, New Faces

Alexandra Schultz | January 13, 2012

The Rheumatologist welcomes new editorial team

ACR Honors Contributions to Rheumatology

Richard Quinn | January 13, 2012

Rheumatologists recognized for their work in the field

Data-Driven, Optimal Patient Care and Clinical Research

James R. O'Dell, MD | January 13, 2012

Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts

A Short History of Rheumatoid Arthritis Therapeutics

Simon M. Helfgott, MD | January 13, 2012

Or, why I chose to become a rheumatologist

The Sexiness of Rheumatology

Ronan Kavanagh, MD | January 13, 2012

Finding the glamour in a humble field

Give Rheumatology Patients a Helping Hand

Staff | January 13, 2012

Nearly 10 million Americans suffer from carpal tunnel syndrome, a condition that disables a key nerve in the wrist resulting in numbness, tingling, weakness, and loss of function in the hands and wrist. These symptoms are similar to those of rheumatoid arthritis and other rheumatic conditions, and it is important that patients know the difference.